Navigation Links
Lifecycle Management Strategies: Pharma-Payer Deals - Creative agreements are used at different stages of the brand lifecycle to maximize sales
Date:9/20/2012

NEW YORK, Sept. 20, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Lifecycle Management Strategies: Pharma-Payer Deals - Creative agreements are used at different stages of the brand lifecycle to maximize sales

http://www.reportlinker.com/p0968553/Lifecycle-Management-Strategies-Pharma-Payer-Deals---Creative-agreements-are-used-at-different-stages-of-the-brand-lifecycle-to-maximize-sales.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

 

With increasing cost-containment measures, payers have emerged as the key decision-making group, as proving the economic and clinical value of a drug is of central importance in achieving commercial success. As a result, pharma-payer deals have been used not only for launch products but also for mature brands in order to drive market share in the face of branded and generic competition alike.Analysis of success drivers and resistors of pharma-payer deals as a lifecycle management strategy.Discussion of how pharma-payer deals can satisfy key stakeholder needs.Case study of recent successful and unsuccessful pharma-payer deals.Risk-sharing agreements are based on a "guaranteed" outcome resulting from the treatment, be that based on financial or outcome/performance criteria. If the outcome is achieved the payer will pay; if not, the pharmaceutical company refunds the payer for the cost of the drug.Risk-sharing agreements have the potential to reconcile the needs of different stakeholders: pharma companies secure market entry, the payer is financially protected from patients who fail to respond to drug treatment, and patients gain access to innovative therapies.While straightforward discount and rebate deals are usually used to maintain sales later in the lifecycle when the drug in question is facing greater competition, recently, creative risk-sharing deals have also been used for mature brands in order to drive market share in the face of branded and generic competition alike.How can pharma-payer deals drive or maintain franchise sales?How can pharma-payer deals be used at different stages of a brand's lifecycle?In which markets are pharma-payer deals commonly used?

 

 

 

EXECUTIVE SUMMARY•Introduction

•Strategic scoping and focus

• Key findings

•Related reports

 

PHARMA-PAYER DEALS OVERVIEW•What are pharma-payer deals? - Early-stage risk-sharing deals to gain reimbursement approval

- Mid- to late-stage LCM pharma-payer deal strategies

 

•Drivers and resistors of pharma-payer deals as lifecycle management strategy

•Pharma-payer deals focus on satisfying payer needs

•Risk-sharing deals are increasing in numbers in the EU - Payer contracting becomes more creative in Germany

 

•US: deals with individual payer organizations are appearing

•Case study summary

 

PHARMA-PAYER DEALS CASE STUDIES•Januvia (sitagliptin) and Janumet (sitagliptin/metformin): Merck & Co. agrees performance-related discounts deal with Cigna - Lesson

- Background

- Impact

 

•Enbrel (etarnecept): Pfizer/Wyeth develop a compliance support program with German payer - Lesson

- Background

- Impact

 

•Aricept (donepezil): Pfizer/Eisai are testing "integrated care" to assess the cost-effectiveness and impact of its dementia drug Aricept - Lesson

- Background

- Impact

 

•Cimzia (certolizumab; UCB): positive recommendation in the UK is based on a patient access scheme - Lesson

- Background

- Impact

 

•Actonel (risendronate; Sanofi/Procter & Gamble): risk-sharing deal used to stave off both generic and branded competition - Lesson

- Background

- Impact

 

•Aclasta (zoledronic acid; Novartis): "no cure, no pay" deal used to boost uptake before new competitor entry - Lesson

- Background

- Impact

 

 

BIBLIOGRAPHY•Publications and online articles

•Datamonitor reports and products

 

APPENDIX•Exchange rates used in this report

 

 

TABLES

•Table: Pharma-payer deals case studies summary

•Table: Currency exchange rates, 2011

 

 

FIGURES

•Figure: Early-stage risk-sharing agreements improve uptake and maximize peak sales

•Figure: Pharma-payer deals can be used in middle and later stages of the brand lifecycle to maximize peak sales and extend sales after patent expiry

•Figure: Drivers and resistors of pharma-payer deals as an LCM strategy

•Figure: Pharma-payer deals need to target key stakeholders' needs to be successful

•Figure: Benefits of a performance-based contract between Merck & Co. and Cigna

•Figure: Benefits of compliance support program between Pfizer/Wyeth and Taunus

•Figure: Benefits of Pfizer/Eisai and AOK dementia study

•Figure: Benefits of patient access scheme between UCB and NICE

•Figure: Actonel's risk-sharing deal in the US is used late in the brand lifecycle to stave off competing generics

•Figure: Aclasta pharma-payer deal in Germany

 

 

 

Companies Mentioned

Hutchison 3G UK Limited, Janssen Pharmaceuticals, Inc.

 

 

 

To order this report:

Drug_and_Medication Industry: Lifecycle Management Strategies: Pharma-Payer Deals - Creative agreements are used at different stages of the brand lifecycle to maximize sales

 

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

 


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Accelrys ELN Advances Innovation Lifecycle Management with Enhanced Biology Capabilities from Screening to Preclinical Development
2. PAREXEL and Salem State University Launch Clinical Trial Management Graduate Program
3. Transdermal Pain Management to 2016: Products, Markets, Forecasts and Opportunities
4. Valeant Pharmaceuticals Announces Management Change
5. ConvaTec, A Leader In Antimicrobial Dressings And Infection Management, To Host Live International Webcast On Minimizing Risk Of Wound Infections
6. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
7. MyEvaluations.com Launches New Medical Education Management Solutions That Meet ACGME NAS Accreditation Requirements
8. Saint Vincent Health System Selects onFocus Healthcare for Enterprise Performance Management
9. Global Airway Management Devices Industry
10. Selfhelp Community Services and FEGS Health & Human Services Launch New Care Management Company: SinglePoint Care Network to Coordinate Care for Seniors & Others With Chronic Medical Conditions in Managed Long Term Care Market
11. Actinium Pharmaceuticals Strengthens Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Collagen Matrix, Inc., ("Collagen Matrix") the driving ... collagen and mineral based medical devices for tissue ... Messer has joined the company as Vice ... growing portfolio of oral surgery, neurosurgery, orthopaedic and ... the Collagen Matrix executive team as an accomplished ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):